Market revenue in 2022 | USD 1,715.4 million |
Market revenue in 2030 | USD 2,226.0 million |
Growth rate | 3.3% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data covered | 2016 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.37% in 2022. Horizon Databook has segmented the North America orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
North America dominated the orthopedic regenerative surgical products market and held the largest revenue share in 2021. This can be attributed to the presence of key players, aging population, and technologically advanced healthcare facilities in the U.S. and Canada. Moreover, favorable healthcare infrastructure in the region contributes to market growth.
Favorable reimbursement policies and quality-driven healthcare model are driving the market demand in the region. The regional market is competitive with presence of major market players. Players such as Baxter, Zimmer Biomet, and Stryker have a strong foothold in the region, which supports regional market growth.
For instance, in November 2020, Stryker completed the acquisition of Wright Medical Group N.V., which strengthened its product offerings and position in the high-growth segment of lower extremity & biologics of the company.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America orthopedic regenerative surgical products market , including forecasts for subscribers. This continent databook contains high-level insights into North America orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account